These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Row over industry link-up splits staff of Spanish lab. Fernandez Hermana LA Nature; 1994 Dec; 372(6507):586. PubMed ID: 7990935 [No Abstract] [Full Text] [Related]
5. Genentech grapples with direct offer. Huggett B Nat Biotechnol; 2009 Mar; 27(3):212. PubMed ID: 19270652 [No Abstract] [Full Text] [Related]
6. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. Holzer LA; Holzer G N Engl J Med; 2009 Dec; 361(26):2579; author reply 2579-80. PubMed ID: 20050321 [No Abstract] [Full Text] [Related]
7. When times get tough. Jong S Nat Biotechnol; 2009 Mar; 27(3):226-8. PubMed ID: 19274868 [No Abstract] [Full Text] [Related]
8. King of the pill. Pfizer is the biggest drug company ever. Can it become the best? Simons J Fortune; 2003 Apr; 147(7):94-6, 100, 102. PubMed ID: 12698860 [No Abstract] [Full Text] [Related]
9. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. Zhang P; Qin L N Engl J Med; 2009 Dec; 361(26):2578-9; author reply 2579-80. PubMed ID: 20032329 [No Abstract] [Full Text] [Related]
10. ▾Xiapex for Dupuytren's contracture. Drug Ther Bull; 2011 Dec; 49(12):138-41. PubMed ID: 22170410 [TBL] [Abstract][Full Text] [Related]
11. Growing against the grain. Boyle M Fortune; 2004 May; 149(9):148-9, 152, 154 passim. PubMed ID: 15124331 [No Abstract] [Full Text] [Related]
12. Biotech battle royale. Two firms fight over billion-dollar drug. Sherrid P US News World Rep; 2000 Mar; 128(11):52. PubMed ID: 10848209 [No Abstract] [Full Text] [Related]
13. New treatment option for Dupuytren's contracture. Mayo Clin Health Lett; 2010 Oct; 28(10):4. PubMed ID: 21033070 [No Abstract] [Full Text] [Related]
16. Unfolding bent fingers: new handiwork for bacteria. Harv Mens Health Watch; 2011 Jan; 15(6):7-8. PubMed ID: 21322908 [No Abstract] [Full Text] [Related]
18. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp]. Westerlund L Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544 [No Abstract] [Full Text] [Related]